Kenes Group to Manage Event with Potential to Change the Future of Diabetes Care and Research: 3rd World Congress on Interventional Therapies for Type 2 Diabetes: WCITT2D 2015

"The advanced scientific program will be coupled with an unparalleled opportunity for attendees to participate in the evaluation of new guidelines and recommendations for the surgical treatment of diabetes," comments Prof. Francesco Rubino, MD, Congress Chair, Chair, Bariatric and Metabolic Surgery King's College London.
GENEVA, Switzerland, (informazione.it - comunicati stampa - salute e benessere)

"The advanced scientific program will be coupled with an unparalleled opportunity for attendees to participate in the evaluation of new guidelines and recommendations for the surgical treatment of diabetes," comments Prof. Francesco Rubino, MD, Congress Chair, Chair, Bariatric and Metabolic Surgery King's College London.

"Attending the 3rd World Congress & DSS-II is a unique opportunity to be a part of and witness history and we invite medical professionals and clinicians to join the world's leading experts and policy makers in this ground-breaking endeavor. More importantly, this is not a specialized surgical conference nor an endocrinology conference, but rather the only forum in the world that brings together physicians, surgeons, basic scientists, industry leaders, and policy makers, while also representing the perspective of patients," he added.

Prof. David e. Cumming, DSS Co-Director, Division of Metabolism, Endocrinology and Nutrition, University of Washington, states  "Cutting-edge evidence related to bariatric/metabolic surgery will be presented and used to generate new, modern guidelines for the use and study of gastrointestinal surgery to treat diabetes, obesity, and other metabolic diseases. We welcome you to witness and participate in this historic event". 

The 3rd World Congress was established to address the challenges and seize the opportunities that surgery offers to diabetes care and research. It is an international forum where a stellar faculty of clinicians, scientists, and policy makers discuss available evidence on the use and study of bariatric/metabolic surgery and new device-based intervention. The overarching aim of the congress is to craft an agenda of research priorities and health policy initiatives. The consensus portion of the meeting (DSS-II) will be attended by global policy-makers and organized in partnership with the American Diabetes Association (ADA), the European Society for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), Diabetes UK, Chinese Diabetes Society and Diabetes India.

To register and for more information, visit the congress website: www.wcitt2d.org.

About Kenes Group
Fifty years of knowledge, experience and market expertise have led Kenes Group to the forefront of global conference management and to becoming one of the world's leading Professional Conference Organizers (PCOs). Founded in Tel Aviv in 1965 and headquartered in Geneva and Tel Aviv, Kenes has hosted over 3,000 conferences in more than 100 cities around the globe, with over 115,000 participants per year. Recognized as the world leader in meeting planning, Kenes is the only global PCO dedicated to medical and scientific events. Kenes boasts a team of over 300 professional, multi-cultural, multi-disciplinary employees in 16 Kenes offices on four continents, with more than 100 returning and long term clients. For more information, visit the website at: www.kenes-group.com.

For more information, contact:
Rachel Zeevy, Congress Secretariat
Tel. +41 22 9080488 Ext. 525
Email. [email protected]

Per maggiori informazioni
Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili